+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
All Genders
ID06340620

Randomized Study Comparing EndoSound Vision System and Standard Echoendoscope for Endoscopic Ultrasound in Gastrointestinal Lesion Evaluation

Led by Orlando Health, Inc. · Updated on 2024-04-01

140

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are comparing the standard echoendoscope with a newly developed device called the EndoSound Visual System to evaluate lesions in the gastrointestinal tract. This trial focuses on improving endoscopic ultrasound EUS examinations, which are commonly used to assess and biopsy lesions in the pancreas, bile duct, lymph nodes, and gastrointestinal tract due to their high sensitivity and accuracy. Participants will undergo EUS examinations using either the standard echoendoscope or the EndoSound Visual System, which attaches externally to a standard endoscope to convert it into an echoendoscope. Each participant will be randomly assigned to one of these two groups, and the EUS procedure will be performed according to standard care practices. During the study, researchers will assess the success rate of completing the EUS examination, ease of device maneuverability, imaging quality, tissue sampling performance, diagnostic adequacy and accuracy of specimens, procedure duration, procedure-related side effects, and costs. These evaluations will take place within one to seven days after the procedure. The total study participation timeline varies by participant based on scheduled assessments and follow-ups.

CONDITIONS

Brief Title

EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope

Research Team

J

Ji Young Bang, MD MPH

B

Barbara Broome

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here